1015777-16-8Relevant articles and documents
Modified PEG-anilinoquinazoline derivatives as potential EGFR PET agents
Dissoki, Samar,Eshet, Renana,Billauer, Hana,Mishani, Eyal
experimental part, p. 41 - 52 (2009/12/01)
Inhibition of epidermal growth factor receptor tyrosine kinase (EGFR-TK) has emerged as a major approach for cancer-targeted therapy. Consequently, there has been a great interest in the use of labeled EGFR-TK inhibitors as positron emission tomography (P